v3.25.3
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues        
Premiums $ 9,081 $ 11,436 $ 30,973 $ 34,493
Net investment income 233 85 707 696
TOTAL REVENUES 69,748 63,694 202,428 181,472
Benefits and expenses        
Pharmacy and other service costs 55,530 47,565 157,196 133,488
Medical costs and other benefit expenses 7,842 9,527 26,089 28,482
Selling, general and administrative expenses 3,362 3,590 11,008 10,979
Amortization of acquired intangible assets 436 436 1,280 1,279
TOTAL BENEFITS AND EXPENSES 67,170 61,118 195,573 174,228
Income from operations 2,578 2,576 6,855 7,244
Interest expense and other (347) (376) (1,046) (1,073)
Gain (loss) on sale of businesses 38 (87) 79 (106)
Net investment gains (losses) 26 (921) 76 (2,805)
Income before income taxes 2,295 1,192 5,964 3,260
TOTAL INCOME TAXES 322 367 950 1,018
Net income 1,973 825 5,014 2,242
Less: Net income attributable to noncontrolling interests 105 86 291 232
SHAREHOLDERS' NET INCOME $ 1,868 $ 739 $ 4,723 $ 2,010
Shareholders' net income per share        
Basic (in dollars per share) $ 7.02 $ 2.65 $ 17.65 $ 7.13
Diluted (in dollars per share) $ 6.98 $ 2.63 $ 17.52 $ 7.05
Pharmacy revenues        
Revenues        
Revenue from contract with customer $ 56,054 $ 48,284 $ 158,336 $ 135,421
Fees and other revenues        
Revenues        
Revenue from contract with customer $ 4,380 $ 3,889 $ 12,412 $ 10,862